The use of Thiocetam in the complex therapy of combat-related brain contusion
Each patient presents a unique set of characteristics and challenges when it comes to acute cerebral ischemia resulting from craniocerebral injury. The aim of this study is to investigate the utilization of Thiocetam as part of a comprehensive treatment approach for combat-related cerebral contus...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2023-07-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/281460/278273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849248399968174080 |
|---|---|
| author | I. F. Bielenichev K. Yu. Nerianov V. I. Chernii D. A. Sereda L. I. Kucherenko N. V. Derevianko К. І. Kandybei |
| author_facet | I. F. Bielenichev K. Yu. Nerianov V. I. Chernii D. A. Sereda L. I. Kucherenko N. V. Derevianko К. І. Kandybei |
| author_sort | I. F. Bielenichev |
| collection | DOAJ |
| description | Each patient presents a unique set of characteristics and challenges when it comes to acute cerebral ischemia resulting from craniocerebral injury.
The aim of this study is to investigate the utilization of Thiocetam as part of a comprehensive treatment approach for combat-related cerebral contusion and to assess the therapeutic effects of Thiocetam in patients with mild and moderate closed combat craniocerebral trauma in comparison to standard basic therapy.
Materials and methods. 79 patients with mild and moderate closed combat craniocerebral trauma were examined. Among them, 76 patients experienced craniocerebral trauma due to an explosive blast injury, which included conditions such as brain concussion, mild cerebral contusion, and cranial vault fractures. All patients were admitted to the department during the acute period of their injuries.
During the study, various clinical and functional methods were employed to assess the condition of the central nervous system. These methods were used to evaluate the effects of the complex treatment administered to the patients.
Results. The administration of Thiocetam to the patients did not result in an increase in excitability, nervousness, or sleep disturbances. Furthermore, the examination of autonomic reactivity following Thiocetam treatment revealed that the indicator of normal autonomic reactivity increased to 60 % in the treated group, whereas it only increased to 42 % in the control group. Additionally, the patients with initially heightened vegetative reactions experienced a decrease from 42.8 % to 17.9 % in the treated group, while the control group saw a decrease from 38.5 % to 23.1 %. In terms of clinical outcomes, a positive effect was observed in 94 % of patients in the Thiocetam-treated group within the first 5 days. In comparison, the control group showed a positive clinical effect in 76 % of cases. This improvement was evident both in the clinical field and based on indicators of autonomic reactivity in EEG data, as well as cognitive function assessed by the MMSE cognitive function test scale.
Conclusions. The utilization of Thiocetam during the acute phase of mild and moderate closed combat craniocerebral trauma enhances the neuroprotective effects of basic therapy. The combined drug Thiocetam, which possesses both nootropic and neuroprotective effects, offers the advantage of reducing or even avoiding the side effects commonly associated with traditional racetam nootropics. |
| format | Article |
| id | doaj-art-e34db58239554a02b6edc44bbd72f162 |
| institution | Kabale University |
| issn | 2306-8094 2409-2932 |
| language | English |
| publishDate | 2023-07-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| spelling | doaj-art-e34db58239554a02b6edc44bbd72f1622025-08-20T03:57:52ZengZaporizhzhia State Medical and Pharmaceutical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322023-07-0116217017410.14739/2409-2932.2023.2.281460The use of Thiocetam in the complex therapy of combat-related brain contusionI. F. Bielenichev0https://orcid.org/0000-0003-1273-5314K. Yu. Nerianov1https://orcid.org/0009-0006-8607-6533V. I. Chernii2https://orcid.org/0000-0002-9885-9248D. A. Sereda3https://orcid.org/0009-0001-1153-1910L. I. Kucherenko4https://orcid.org/0000-0003-2229-0232N. V. Derevianko5https://orcid.org/0000-0003-3349-867XК. І. Kandybei6https://orcid.org/0000-0001-7131-2704Zaporizhzhia State Medical and Pharmaceutical University, UkraineLLC SPA “Pharmatron”, Zaporizhzhia, UkraineState Scientific Institution “Scientific and Practical Center of Preventive and Clinical Medicine” of the State Administration of Affairs, Kyiv, UkraineLLC SPA “Pharmatron”, Zaporizhzhia, UkraineZaporizhzhia State Medical and Pharmaceutical University, UkraineZaporizhzhia State Medical and Pharmaceutical University, UkraineZaporizhzhia State Medical and Pharmaceutical University, UkraineEach patient presents a unique set of characteristics and challenges when it comes to acute cerebral ischemia resulting from craniocerebral injury. The aim of this study is to investigate the utilization of Thiocetam as part of a comprehensive treatment approach for combat-related cerebral contusion and to assess the therapeutic effects of Thiocetam in patients with mild and moderate closed combat craniocerebral trauma in comparison to standard basic therapy. Materials and methods. 79 patients with mild and moderate closed combat craniocerebral trauma were examined. Among them, 76 patients experienced craniocerebral trauma due to an explosive blast injury, which included conditions such as brain concussion, mild cerebral contusion, and cranial vault fractures. All patients were admitted to the department during the acute period of their injuries. During the study, various clinical and functional methods were employed to assess the condition of the central nervous system. These methods were used to evaluate the effects of the complex treatment administered to the patients. Results. The administration of Thiocetam to the patients did not result in an increase in excitability, nervousness, or sleep disturbances. Furthermore, the examination of autonomic reactivity following Thiocetam treatment revealed that the indicator of normal autonomic reactivity increased to 60 % in the treated group, whereas it only increased to 42 % in the control group. Additionally, the patients with initially heightened vegetative reactions experienced a decrease from 42.8 % to 17.9 % in the treated group, while the control group saw a decrease from 38.5 % to 23.1 %. In terms of clinical outcomes, a positive effect was observed in 94 % of patients in the Thiocetam-treated group within the first 5 days. In comparison, the control group showed a positive clinical effect in 76 % of cases. This improvement was evident both in the clinical field and based on indicators of autonomic reactivity in EEG data, as well as cognitive function assessed by the MMSE cognitive function test scale. Conclusions. The utilization of Thiocetam during the acute phase of mild and moderate closed combat craniocerebral trauma enhances the neuroprotective effects of basic therapy. The combined drug Thiocetam, which possesses both nootropic and neuroprotective effects, offers the advantage of reducing or even avoiding the side effects commonly associated with traditional racetam nootropics.http://pharmed.zsmu.edu.ua/article/view/281460/278273nootropic agentsbrain injuriesoxidative stressneuroprotective agentscontusionscognitive function |
| spellingShingle | I. F. Bielenichev K. Yu. Nerianov V. I. Chernii D. A. Sereda L. I. Kucherenko N. V. Derevianko К. І. Kandybei The use of Thiocetam in the complex therapy of combat-related brain contusion Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki nootropic agents brain injuries oxidative stress neuroprotective agents contusions cognitive function |
| title | The use of Thiocetam in the complex therapy of combat-related brain contusion |
| title_full | The use of Thiocetam in the complex therapy of combat-related brain contusion |
| title_fullStr | The use of Thiocetam in the complex therapy of combat-related brain contusion |
| title_full_unstemmed | The use of Thiocetam in the complex therapy of combat-related brain contusion |
| title_short | The use of Thiocetam in the complex therapy of combat-related brain contusion |
| title_sort | use of thiocetam in the complex therapy of combat related brain contusion |
| topic | nootropic agents brain injuries oxidative stress neuroprotective agents contusions cognitive function |
| url | http://pharmed.zsmu.edu.ua/article/view/281460/278273 |
| work_keys_str_mv | AT ifbielenichev theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT kyunerianov theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT vichernii theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT dasereda theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT likucherenko theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT nvderevianko theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT kíkandybei theuseofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT ifbielenichev useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT kyunerianov useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT vichernii useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT dasereda useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT likucherenko useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT nvderevianko useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion AT kíkandybei useofthiocetaminthecomplextherapyofcombatrelatedbraincontusion |